Orgenesis Inc Shares Fall 1.3% Below Previous 52-Week Low - Market Mover

The shares fell 1.3% lower than its previous 52-week low of $2.34, with trading volume lower than its 30 day average

Jan 14, 2022 by Kwhen Finance Editors

Orgenesis Inc Shares Fall 1.3% Below Previous 52-Week Low - Market Mover
Orgenesis Inc (ORGS) shares closed 1.3% lower than its previous 52 week low, giving the company a market cap of $59M. The stock is currently down 14.9% year-to-date, down 52.7% over the past 12 months, and up 390.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%.

Trading Activity

  • Trading volume this week was 33.9% lower than the 20-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 1.7.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed above its Bollinger band, indicating it may be overbought.

Market Comparative Performance

  • The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis
  • The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis
  • The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Orgenesis Inc-5.7-14.9-52.7-71.03.0
Dow Jones Industrial Average-0.5-0.118.8-1.424.0
S&P 500 Index-1.4-0.826.0-1.629.9
Health Care-1.8-3.815.2-4.522.7

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by -693.7%
  • The company's stock price performance over the past 12 months lags the peer average by 250.3%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Orgenesis IncORGS0-14.9-52.7-71.03.0
Peer AvgN/A4.12.5-15.0-21.516.0
National Research CorpNRC27.3-6.9-14.9-30.10.2
Nymox Pharmaceutical CorpNYMX-11.116.9-45.3-56.063.8

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: